Therapeutic Drug Monitoring in Psychiatry

Pharmacopsychiatry 2011; 44(06): 193-194
DOI: 10.1055/s-0031-1286286

Editorial

Georg Thieme Verlag KG Stuttgart · New York

Authors

A. Conca

¹Psychiatric Hospital, Bolzano, Italy
P. Baumann

²Department of Psychiatry, University of Lausanne, Prilly-Lausanne, Switzerland
C. Hiemke

³Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Germany

References
1 Baumann P, Hiemke C, Ulrich S et al. Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004; 37: 243-265
2 Kuss HJ, Jungkunz G, Holsboer F. Amitriptyline: looking through the therapeutic window. Lancet 1984; 25: 464-465